Metraipolis › archive › dc_e2e475bbe431
Chromatin accessibility derived from cfDNA serves as a novel classification biomarker of glioma — Europe PMC PMID:41473442
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41473442
- DOI
- 10.3389/fonc.2025.1688625
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T15:39:08.959Z
- SHA-256 of the archived text
a0c27a8ac57357134549300df36ad9049da6938d8e0e95c555a3781e2240851c- Stable URL of this page
https://metraipolis.com/documento/dc_e2e475bbe431
How to cite
Chromatin accessibility derived from cfDNA serves as a novel classification biomarker of glioma — Europe PMC PMID:41473442 — Europe PMC (en), https://europepmc.org/article/MED/41473442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2e475bbe431 (Metraipolis archive dc_e2e475bbe431, sha256 a0c27a8ac57357134549300df36ad9049da6938d8e0e95c555a3781e2240851c)
BibTeX
@misc{dce2e475bbe431,
title = {Chromatin accessibility derived from cfDNA serves as a novel classification biomarker of glioma — Europe PMC PMID:41473442},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41473442},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2e475bbe431; sha256 a0c27a8ac57357134549300df36ad9049da6938d8e0e95c555a3781e2240851c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41473442. Agents can read the archived copy with the MCP tool read_document.